MetaSight

Multiomic Health

This company develops an artificial intelligence platform for discovering precision medicines and biomarkers for patients with metabolic syndrome-related chronic diseases.

Molecular Stethoscope

This company develops blood-based liquid biopsy tests that analyse cell-free messenger RNA to help clinicians and researchers detect and monitor diseases.

Xgenera

Xgenera develops a multi-cancer early detection blood test to help clinicians and patients identify multiple cancer types at their earliest stages.

Flomics

Flomics develops liquid biopsy blood tests and a bioinformatics platform for early cancer detection in clinical and research settings.

Infiniplex

This company develops liquid biopsy solutions using blood tests to monitor genetic biomarkers for cancer screening and precision oncology decisions for healthcare providers.

Single molecule diagnostics

This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.

Foresight Diagnostics

This company develops liquid biopsy tests to detect minimal residual disease in cancer patients for biopharmaceutical companies and healthcare providers.

Genomill Health

Genomill Health develops targeted sequencing technology for liquid biopsies to assist clinical laboratories and pharmaceutical companies with precision cancer diagnostics.